# Markus Moehler

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/markus-moehler/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,445 |
| Field | Gastric Cancer Management and Outcomes |
| h-index | 64 |
| i10-index | 208 |
| OpenAlex ID | https://openalex.org/A5038131926 |
| Works | 518 |

## Researcher papers

- [Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer](https://scholariq.org/papers/adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer/)
- [Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial](https://scholariq.org/papers/chemoradiotherapy-with-capecitabine-versus-fluorouracil-for-locally-advanced/)

## Researcher topics

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.